| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.14 | 0.7 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |